Naoko Kanda

74PUBLICATIONS
25CO-AUTHORS
Traditional Chinese medicine and treatmentsAllergyClinical pharmacology and therapeuticsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (74)

|Jul 01, 2026
Real-World Effectiveness of Tildrakizumab in Japanese Patients With Psoriasis: Analyses Stratified by Prior Systemic Therapy, Maintenance of Early Responses, and Achievement of Delayed Responses.

|Feb 16, 2026
Seventy-Two-Week Real-World Outcomes of Tralokinumab Treatment for Moderate-To-Severe Atopic Dermatitis: Analyses Stratified by Baseline Rash and Itch Severity.

Manami Yoneyama, Teppei Hagino, Akihiko Uchiyama

|Feb 11, 2026
Effectiveness of Anti-IL-13 Antibodies on Head and Neck Lesions in Atopic Dermatitis: 48-Week Outcomes by Lebrikizumab and Tralokinumab.

Mizuki Shiba, Teppei Hagino, Akihiko Uchiyama

|Feb 11, 2026
Effectiveness of Apremilast in Patients With Palmoplantar Pustulosis: A 28-Week Real-World Study.

Yohei Takahashi, Teppei Hagino, Hidehisa Saeki

|Feb 09, 2026
Two-Year Real-World Effectiveness of Deucravacitinib in Psoriasis: The Analysis Stratified by Prior Apremilast or Biologic Therapy.

Ryo Ishihara, Teppei Hagino, Yohei Takahashi

|Jan 05, 2026
Two-Year Real-World Effectiveness of Deucravacitinib 6 mg in Psoriasis: A Single-Center Analysis Stratified by Body Mass Index or Age in a Japanese Cohort.

Yuriko Okabe, Teppei Hagino, Yohei Takahashi

Pageof 13

Frequent Collaborators

54 joint publications

Hidehisa Saeki

44 joint publications

Teppei Hagino

7 joint publications

Susumu Ichiyama

7 joint publications

Eita Fujimoto